Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
暂无分享，去创建一个
R. Greil | V. Diehl | J. Franklin | M. Pfreundschuh | B. Lathan | U. Paulus | D. Hasenclever | H. Tesch | R. Herrmann | M. Loeffler | J. Wolf | M. Sieber | B. Pfistner | R. Munker | A. Engert | A. Georgii | H. Kirchner | P. Koch | O. Brosteanu | A. Josting | A. Anselmo | U. Rueffer | T. Koch | K. Schalk | E. Duehmke | G. Doelken